CreditReports.dk
HomeScreen companies

PEROZIN ApS Financials, key figures and credit report

CVR number: 29183910 Advertising protected Established 2005 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details

The company is advertising protected in the CVR register and does not want to be contacted for direct marketing.

Danmarksgade 4, 4690 Haslev gh@perozin.com tel: 20204270 www.perozin.com
Gross profit 1 943.7 kDKK FY 2025 -30.6% vs 2024
EBIT 1 013.2 kDKK FY 2025 -40% vs 2024
Net debt 101.6 kDKK FY 2025 -90.9% vs 2024
Quick ratio 1.7 FY 2025 +0.5 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit2 020.871 634.411 846.692 799.721 943.66
Employee benefit expenses- 563.70- 346.83- 363.14- 514.17- 720.25
Other operating expenses- 342.82
Total depreciation- 133.00-79.88- 248.18- 254.40- 210.23
EBIT1 324.171 207.701 235.381 688.331 013.18
Other financial income0.9533.43
Other financial expenses-41.85-46.07- 109.86- 319.15- 270.11
Pre-tax profit1 282.321 161.631 125.511 369.19776.51
Income taxes- 282.61- 257.42- 389.43- 343.06- 146.34
Net earnings999.71904.21736.081 026.12630.17

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Land and waters414.38414.388 661.209 809.369 525.22
Machinery and equipment225.79145.92699.2664.2141.39
Advance payments and construction in progress655.31778.74
Tangible assets total1 295.491 339.049 360.469 873.579 566.61
Investments total65.0265.0265.02
Long term receivables total
Raw materials and consumables316.43296.38268.95259.34332.27
Inventories total316.43296.38268.95259.34332.27
Current trade debtors711.49705.68680.27331.73889.56
Current amounts owed by group member comp.112.21102.66180.59234.50468.82
Prepayments and accrued income388.00342.82342.8290.2644.47
Current other receivables95.0486.631 032.651 281.99167.95
Current deferred tax assets2.57
Short term receivables total1 306.731 240.362 236.331 938.491 570.80
Cash and bank deposits4 501.415 565.131 234.822 368.451 562.00
Cash and cash equivalents4 501.415 565.131 234.822 368.451 562.00
Balance sheet total (assets)7 485.088 505.9313 165.5914 439.8513 031.67

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital178.57178.57178.57178.57178.57
Retained earnings5 799.336 799.047 703.258 439.339 465.45
Profit of the financial year999.71904.21736.081 026.12630.17
Shareholders equity total6 977.617 881.828 617.909 644.0210 274.20
Provisions0.66183.19235.94225.46
Non-current loans from credit institutions1 134.69864.38570.54
Non-current other liabilities-97.83
Non-current deferred tax liabilities393.37260.66203.68290.31168.89
Non-current liabilities total295.53260.661 338.361 154.69739.43
Current loans from credit institutions858.761 814.02273.12
Current trade creditors43.0035.00775.34273.06339.35
Current owed to participating108.26806.71807.09819.90
Short-term deferred tax liabilities104.69295.53556.19479.62290.31
Other non-interest bearing current liabilities-44.6932.9229.1331.3969.91
Current liabilities total211.27363.453 026.143 405.201 792.58
Balance sheet total (liabilities)7 485.088 505.9313 165.5914 439.8513 031.67
Page generated